nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—SERPINC1—Common Pathway—SERPINE2—chronic obstructive pulmonary disease	0.0619	0.166	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Intrinsic Pathway—SERPINE2—chronic obstructive pulmonary disease	0.0528	0.142	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—SERPINE2—chronic obstructive pulmonary disease	0.0356	0.0955	CbGpPWpGaD
Fondaparinux sodium—F10—Common Pathway—SERPINE2—chronic obstructive pulmonary disease	0.035	0.0939	CbGpPWpGaD
Fondaparinux sodium—F10—Intrinsic Pathway—SERPINE2—chronic obstructive pulmonary disease	0.0298	0.08	CbGpPWpGaD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—SERPINE2—chronic obstructive pulmonary disease	0.0201	0.0539	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—SERPINA1—chronic obstructive pulmonary disease	0.012	0.0323	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—PLAUR—chronic obstructive pulmonary disease	0.00844	0.0226	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—PLAUR—chronic obstructive pulmonary disease	0.00841	0.0226	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—PLAU—chronic obstructive pulmonary disease	0.00736	0.0198	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—SERPINA1—chronic obstructive pulmonary disease	0.0068	0.0182	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—VEGFA—chronic obstructive pulmonary disease	0.00606	0.0163	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—PLAU—chronic obstructive pulmonary disease	0.00592	0.0159	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—PLAU—chronic obstructive pulmonary disease	0.0059	0.0158	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—SERPINE1—chronic obstructive pulmonary disease	0.00569	0.0153	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—TGFB1—chronic obstructive pulmonary disease	0.00557	0.0149	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—PLAUR—chronic obstructive pulmonary disease	0.00477	0.0128	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—SERPINE1—chronic obstructive pulmonary disease	0.00458	0.0123	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.00429	0.0115	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—MUC5AC—chronic obstructive pulmonary disease	0.00402	0.0108	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.00375	0.0101	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—MUC1—chronic obstructive pulmonary disease	0.00342	0.00918	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—PLAU—chronic obstructive pulmonary disease	0.00334	0.00897	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—SERPINE1—chronic obstructive pulmonary disease	0.00259	0.00694	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.00243	0.00651	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.00216	0.00579	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.00212	0.00569	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.00191	0.00512	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.00187	0.00502	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.00168	0.0045	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.00162	0.00436	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.00151	0.00406	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—PLAUR—chronic obstructive pulmonary disease	0.00142	0.0038	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.00122	0.00327	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.00108	0.0029	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.00106	0.00285	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.00106	0.00283	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000974	0.00261	CbGpPWpGaD
Fondaparinux sodium—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000952	0.00152	CcSEcCtD
Fondaparinux sodium—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000949	0.00151	CcSEcCtD
Fondaparinux sodium—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000948	0.00151	CcSEcCtD
Fondaparinux sodium—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000948	0.00151	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000947	0.00254	CbGpPWpGaD
Fondaparinux sodium—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000945	0.00151	CcSEcCtD
Fondaparinux sodium—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000945	0.00151	CcSEcCtD
Fondaparinux sodium—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000945	0.00151	CcSEcCtD
Fondaparinux sodium—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000945	0.00151	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000944	0.00151	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000944	0.00151	CcSEcCtD
Fondaparinux sodium—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000943	0.0015	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000942	0.0015	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000942	0.0015	CcSEcCtD
Fondaparinux sodium—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000929	0.00148	CcSEcCtD
Fondaparinux sodium—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000926	0.00148	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000924	0.00147	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000922	0.00147	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000921	0.00147	CcSEcCtD
Fondaparinux sodium—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000918	0.00146	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000909	0.00145	CcSEcCtD
Fondaparinux sodium—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000909	0.00145	CcSEcCtD
Fondaparinux sodium—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000909	0.00145	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000909	0.00145	CcSEcCtD
Fondaparinux sodium—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000903	0.00144	CcSEcCtD
Fondaparinux sodium—Infection—Formoterol—chronic obstructive pulmonary disease	0.000903	0.00144	CcSEcCtD
Fondaparinux sodium—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000895	0.00143	CcSEcCtD
Fondaparinux sodium—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000895	0.00143	CcSEcCtD
Fondaparinux sodium—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000892	0.00142	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000892	0.00142	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000892	0.00142	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00089	0.00142	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00089	0.00142	CcSEcCtD
Fondaparinux sodium—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00089	0.00142	CcSEcCtD
Fondaparinux sodium—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000887	0.00141	CcSEcCtD
Fondaparinux sodium—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000887	0.00141	CcSEcCtD
Fondaparinux sodium—Infection—Montelukast—chronic obstructive pulmonary disease	0.000885	0.00141	CcSEcCtD
Fondaparinux sodium—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000883	0.00141	CcSEcCtD
Fondaparinux sodium—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000883	0.00141	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00088	0.0014	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000873	0.00139	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000872	0.00139	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000872	0.00139	CcSEcCtD
Fondaparinux sodium—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.00087	0.00139	CcSEcCtD
Fondaparinux sodium—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000865	0.00138	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000858	0.00137	CcSEcCtD
Fondaparinux sodium—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000858	0.00137	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000854	0.00229	CbGpPWpGaD
Fondaparinux sodium—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000853	0.00136	CcSEcCtD
Fondaparinux sodium—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000849	0.00135	CcSEcCtD
Fondaparinux sodium—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000849	0.00135	CcSEcCtD
Fondaparinux sodium—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000845	0.00135	CcSEcCtD
Fondaparinux sodium—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000845	0.00135	CcSEcCtD
Fondaparinux sodium—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000843	0.00134	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000842	0.00134	CcSEcCtD
Fondaparinux sodium—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000838	0.00134	CcSEcCtD
Fondaparinux sodium—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000834	0.00133	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00083	0.00132	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00083	0.00132	CcSEcCtD
Fondaparinux sodium—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000822	0.00131	CcSEcCtD
Fondaparinux sodium—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000822	0.00131	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.00082	0.0022	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000819	0.0022	CbGpPWpGaD
Fondaparinux sodium—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000818	0.0013	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000817	0.0013	CcSEcCtD
Fondaparinux sodium—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000814	0.0013	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00081	0.00129	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00081	0.00129	CcSEcCtD
Fondaparinux sodium—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000808	0.00129	CcSEcCtD
Fondaparinux sodium—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000808	0.00129	CcSEcCtD
Fondaparinux sodium—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000805	0.00128	CcSEcCtD
Fondaparinux sodium—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000803	0.00128	CcSEcCtD
Fondaparinux sodium—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000802	0.00128	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.0008	0.00128	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.0008	0.00128	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.0008	0.00127	CcSEcCtD
Fondaparinux sodium—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000797	0.00127	CcSEcCtD
Fondaparinux sodium—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000792	0.00126	CcSEcCtD
Fondaparinux sodium—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00079	0.00126	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000785	0.00125	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000785	0.00125	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000784	0.00125	CcSEcCtD
Fondaparinux sodium—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000784	0.00125	CcSEcCtD
Fondaparinux sodium—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000784	0.00125	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000783	0.0021	CbGpPWpGaD
Fondaparinux sodium—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000777	0.00124	CcSEcCtD
Fondaparinux sodium—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000777	0.00124	CcSEcCtD
Fondaparinux sodium—Pain—Formoterol—chronic obstructive pulmonary disease	0.000777	0.00124	CcSEcCtD
Fondaparinux sodium—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000777	0.00124	CcSEcCtD
Fondaparinux sodium—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000776	0.00124	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000771	0.00123	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000769	0.00123	CcSEcCtD
Fondaparinux sodium—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000768	0.00122	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000765	0.00122	CcSEcCtD
Fondaparinux sodium—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000763	0.00122	CcSEcCtD
Fondaparinux sodium—Pain—Montelukast—chronic obstructive pulmonary disease	0.000761	0.00121	CcSEcCtD
Fondaparinux sodium—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000761	0.00121	CcSEcCtD
Fondaparinux sodium—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000759	0.00121	CcSEcCtD
Fondaparinux sodium—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000757	0.00121	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000756	0.0012	CcSEcCtD
Fondaparinux sodium—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000755	0.0012	CcSEcCtD
Fondaparinux sodium—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000753	0.0012	CcSEcCtD
Fondaparinux sodium—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000752	0.0012	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000749	0.00119	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000749	0.00119	CcSEcCtD
Fondaparinux sodium—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000748	0.00119	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000748	0.00201	CbGpPWpGaD
Fondaparinux sodium—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000746	0.00119	CcSEcCtD
Fondaparinux sodium—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000746	0.00119	CcSEcCtD
Fondaparinux sodium—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000745	0.00119	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000743	0.00118	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000743	0.00118	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000741	0.00118	CcSEcCtD
Fondaparinux sodium—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00074	0.00118	CcSEcCtD
Fondaparinux sodium—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000734	0.00117	CcSEcCtD
Fondaparinux sodium—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000734	0.00117	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000728	0.00116	CcSEcCtD
Fondaparinux sodium—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000722	0.00115	CcSEcCtD
Fondaparinux sodium—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000722	0.00115	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000719	0.00115	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000719	0.00115	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000719	0.00115	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000719	0.00115	CcSEcCtD
Fondaparinux sodium—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000716	0.00114	CcSEcCtD
Fondaparinux sodium—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00071	0.00113	CcSEcCtD
Fondaparinux sodium—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00071	0.00113	CcSEcCtD
Fondaparinux sodium—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000709	0.00113	CcSEcCtD
Fondaparinux sodium—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000707	0.00113	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000707	0.00113	CcSEcCtD
Fondaparinux sodium—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000706	0.00112	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000704	0.00112	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000704	0.00112	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000702	0.00112	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000696	0.00111	CcSEcCtD
Fondaparinux sodium—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000695	0.00111	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000693	0.0011	CcSEcCtD
Fondaparinux sodium—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000692	0.0011	CcSEcCtD
Fondaparinux sodium—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000682	0.00109	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000679	0.00108	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000679	0.00108	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000672	0.0018	CbGpPWpGaD
Fondaparinux sodium—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00067	0.00107	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00067	0.00107	CcSEcCtD
Fondaparinux sodium—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000669	0.00107	CcSEcCtD
Fondaparinux sodium—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000662	0.00106	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000656	0.00105	CcSEcCtD
Fondaparinux sodium—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000652	0.00104	CcSEcCtD
Fondaparinux sodium—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000652	0.00104	CcSEcCtD
Fondaparinux sodium—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000643	0.00103	CcSEcCtD
Fondaparinux sodium—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000643	0.00103	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000642	0.00102	CcSEcCtD
Fondaparinux sodium—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000639	0.00102	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000633	0.00101	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000632	0.00101	CcSEcCtD
Fondaparinux sodium—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00063	0.001	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000622	0.000991	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000622	0.000991	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000619	0.000987	CcSEcCtD
Fondaparinux sodium—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000616	0.000982	CcSEcCtD
Fondaparinux sodium—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000613	0.000977	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.00061	0.00164	CbGpPWpGaD
Fondaparinux sodium—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000609	0.000971	CcSEcCtD
Fondaparinux sodium—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000607	0.000968	CcSEcCtD
Fondaparinux sodium—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000601	0.000958	CcSEcCtD
Fondaparinux sodium—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000601	0.000958	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000599	0.00161	CbGpPWpGaD
Fondaparinux sodium—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000589	0.000939	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000587	0.000936	CcSEcCtD
Fondaparinux sodium—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000578	0.000921	CcSEcCtD
Fondaparinux sodium—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000578	0.000921	CcSEcCtD
Fondaparinux sodium—Rash—Formoterol—chronic obstructive pulmonary disease	0.000573	0.000914	CcSEcCtD
Fondaparinux sodium—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000573	0.000914	CcSEcCtD
Fondaparinux sodium—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000573	0.000913	CcSEcCtD
Fondaparinux sodium—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000573	0.000913	CcSEcCtD
Fondaparinux sodium—Headache—Formoterol—chronic obstructive pulmonary disease	0.00057	0.000908	CcSEcCtD
Fondaparinux sodium—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00057	0.000908	CcSEcCtD
Fondaparinux sodium—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000569	0.000906	CcSEcCtD
Fondaparinux sodium—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000568	0.000905	CcSEcCtD
Fondaparinux sodium—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000566	0.000902	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000564	0.00151	CbGpPWpGaD
Fondaparinux sodium—Rash—Montelukast—chronic obstructive pulmonary disease	0.000561	0.000895	CcSEcCtD
Fondaparinux sodium—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000561	0.000894	CcSEcCtD
Fondaparinux sodium—Headache—Montelukast—chronic obstructive pulmonary disease	0.000558	0.000889	CcSEcCtD
Fondaparinux sodium—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000553	0.000881	CcSEcCtD
Fondaparinux sodium—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000551	0.000879	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.00055	0.00148	CbGpPWpGaD
Fondaparinux sodium—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.00055	0.000876	CcSEcCtD
Fondaparinux sodium—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000546	0.00087	CcSEcCtD
Fondaparinux sodium—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000542	0.000864	CcSEcCtD
Fondaparinux sodium—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000541	0.000863	CcSEcCtD
Fondaparinux sodium—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000541	0.000862	CcSEcCtD
Fondaparinux sodium—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000541	0.000862	CcSEcCtD
Fondaparinux sodium—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00054	0.000861	CcSEcCtD
Fondaparinux sodium—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00054	0.000861	CcSEcCtD
Fondaparinux sodium—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000538	0.000857	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00053	0.000845	CcSEcCtD
Fondaparinux sodium—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000529	0.000843	CcSEcCtD
Fondaparinux sodium—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000523	0.000833	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000518	0.00139	CbGpPWpGaD
Fondaparinux sodium—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00051	0.000813	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000506	0.000807	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000504	0.000803	CcSEcCtD
Fondaparinux sodium—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000492	0.000785	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000492	0.000785	CcSEcCtD
Fondaparinux sodium—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000484	0.000772	CcSEcCtD
Fondaparinux sodium—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00048	0.000766	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.00048	0.00129	CbGpPWpGaD
Fondaparinux sodium—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000476	0.000759	CcSEcCtD
Fondaparinux sodium—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000467	0.000745	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000465	0.00125	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000464	0.00124	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000463	0.00124	CbGpPWpGaD
Fondaparinux sodium—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000457	0.000728	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000455	0.000725	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00045	0.000717	CcSEcCtD
Fondaparinux sodium—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000445	0.00071	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000443	0.00119	CbGpPWpGaD
Fondaparinux sodium—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000442	0.000705	CcSEcCtD
Fondaparinux sodium—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000438	0.000699	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000426	0.00114	CbGpPWpGaD
Fondaparinux sodium—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000421	0.000671	CcSEcCtD
Fondaparinux sodium—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000413	0.000659	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000406	0.000647	CcSEcCtD
Fondaparinux sodium—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000405	0.000646	CcSEcCtD
Fondaparinux sodium—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000401	0.000638	CcSEcCtD
Fondaparinux sodium—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000394	0.000628	CcSEcCtD
Fondaparinux sodium—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000393	0.000627	CcSEcCtD
Fondaparinux sodium—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000391	0.000623	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000385	0.000614	CcSEcCtD
Fondaparinux sodium—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00038	0.000605	CcSEcCtD
Fondaparinux sodium—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000372	0.000593	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000371	0.000591	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000363	0.000578	CcSEcCtD
Fondaparinux sodium—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000358	0.00057	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000358	0.00057	CcSEcCtD
Fondaparinux sodium—Infection—Prednisone—chronic obstructive pulmonary disease	0.000355	0.000567	CcSEcCtD
Fondaparinux sodium—Shock—Prednisone—chronic obstructive pulmonary disease	0.000352	0.000561	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000351	0.000559	CcSEcCtD
Fondaparinux sodium—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000349	0.000557	CcSEcCtD
Fondaparinux sodium—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000347	0.000554	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000346	0.000551	CcSEcCtD
Fondaparinux sodium—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000341	0.000544	CcSEcCtD
Fondaparinux sodium—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000326	0.000519	CcSEcCtD
Fondaparinux sodium—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000324	0.000516	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000321	0.000512	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000319	0.000856	CbGpPWpGaD
Fondaparinux sodium—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000315	0.000502	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000311	0.000496	CcSEcCtD
Fondaparinux sodium—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00031	0.000495	CcSEcCtD
Fondaparinux sodium—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00031	0.000494	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.000309	0.000829	CbGpPWpGaD
Fondaparinux sodium—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000308	0.000492	CcSEcCtD
Fondaparinux sodium—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000308	0.000492	CcSEcCtD
Fondaparinux sodium—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000306	0.000488	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000295	0.00047	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000293	0.000785	CbGpPWpGaD
Fondaparinux sodium—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000293	0.000466	CcSEcCtD
Fondaparinux sodium—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000292	0.000466	CcSEcCtD
Fondaparinux sodium—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000284	0.000453	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000283	0.000451	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000283	0.000451	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000264	0.00042	CcSEcCtD
Fondaparinux sodium—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000257	0.000409	CcSEcCtD
Fondaparinux sodium—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000253	0.000403	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000245	0.00039	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000241	0.000646	CbGpPWpGaD
Fondaparinux sodium—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000237	0.000377	CcSEcCtD
Fondaparinux sodium—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000363	CcSEcCtD
Fondaparinux sodium—Rash—Prednisone—chronic obstructive pulmonary disease	0.000226	0.00036	CcSEcCtD
Fondaparinux sodium—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000225	0.000359	CcSEcCtD
Fondaparinux sodium—Headache—Prednisone—chronic obstructive pulmonary disease	0.000224	0.000357	CcSEcCtD
Fondaparinux sodium—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000213	0.000339	CcSEcCtD
